Research Use Only. Not for human or animal consumption. Not for injection, ingestion, medical, cosmetic, dietary, or therapeutic use.

Product image coming soon

Metabolic & Weight Loss

Retatrutide (Reta)

10mg

Triple-agonist GLP-1/GIP/GCGR peptide for advanced metabolic research.

$249.00In Stock
Dosage
10mg
Purity
≥ 98% (HPLC tested)
Form
Lyophilized Powder
SKU
VLT-RETA-10
Kit Contents
10mg sterile lyophilized powder vial
1
HPLC tested
Sterile vial
ISO facility
Research-ready

Retatrutide is an absolute pinnacle in modern metabolic and obesity research. It represents a single peptide chain engineered to act as a Triple Agonist targeting three distinct metabolic receptors: GLP-1 (Glucagon-Like Peptide-1), GIP (Gastric Inhibitory Polypeptide), and GCGR (Glucagon Receptor). While older agents only target GLP-1, Retatrutide's triple-action mechanism completely alters metabolic rate. The GLP-1 and GIP components cause delayed gastric emptying and signal intense satiety to the brain, while the Glucagon receptor agonist component upregulates energy expenditure and thermogenesis directly inside liver cells.